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SUMMARY 
Candidiasis is the most common opportunistic yeast infection. Candida species and 
other microorganisms are involved in this complicated fungal infection, but Candida 
albicans continues to be the most prevalent. In the past two decades, it has been 
observed an abnormal overgrowth in the gastrointestinal, urinary and respiratory tracts, 
not only in immunocompromised patients, but also related to nosocomial infections and 
even in healthy individuals. There is a widely variety of causal factors that contribute to 
yeast infection which means that candidiasis is a good example of a multifactorial 
syndrome. Due to rapid increase in the incidence of these infections, this is the subject 
of numerous studies. Recently, the focus of attention is the treatment and, above all, the 
prevention of those complications. The diagnosis of candidiasis could become quite 
complicated. Prevention is the most effective “treatment”, much more than eradication 
of the yeast with antifungal agents. There are several aspects to consider in the daily 
routine that can provide a strength protection. However, a therapeutic approach is 
necessary when the infection is established and, therefore, other alternatives should be 
explored. This review provides an overview on predisposition factors, prevention and 
diagnosis of candidiasis, highlighting alternative approaches for candidiasis treatment. 
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1. Introduction 
Candida species are involved in the main opportunistic yeast infection in the world, 
candidiasis, but among the species of the genus, Candida albicans continues to be the 
most common. Although this yeast is responsible for approximately 50-90% of human 
candidiasis, C. albicans is part of the commensal flora of more than half of the healthy 
population. Colonization by this yeast is beneficial to the host, because not only limits 
the growth of other opportunistic pathogenic fungi, but also promotes the functioning of 
the immune system [1–5]. 
In the last two decades, it has been observed a considerable increase in the incidence of 
deep fungal infections, not only in immunocompromised patients, but also related to 
nosocomial infections, and even in healthy population [4,6–15]. Thus, with the 
increased incidence of deep fungal infections (chronic candidiasis), the primitive idea 
that they were related to a restrict number of pathogenic fungi and specific geographical 
area was completely changed. Furthermore, with the rapid increase of candidiasis 
incidence, other Candida species and microorganisms besides C. albicans, have been 
involved in such infections [2,5,6,16–18]. The balance between C. albicans and non-
Candida albicans Candida (NCAC) species determine the profiles associated with 
virulence. So, the most common species are C. albicans, C. tropicalis, C. glabrata, C. 
dubliniensis, C. parapsilosis, C. orthopsilosis, C. metapsilosis, C. krusei, C. famata, C. 
guilliermondii and C. lusitaniae. Other relevant fact associated with virulence is their 
capacity to form biofilms with other species, which together with the presence of 
teleomorph forms (sexual phase of fungi in which the same biologic entity could have 
two different scientific names), difficult the treatment and alter the susceptibility 
profiles to traditional antifungals agents [3,9,10,13,19–22].  
4 
Although biofilm formation lead to an increase in the persistence and resistance to 
antifungals, other factors, like adaptation to the pH level, adherence of yeast cells to the 
host cells, proteolytic enzymes, phenotypic switching, and morphological transition 
(ability of yeast to change morphologically from blastoconidia to pseudohyphae and 
hyphae), affect the strategies to prevent and treat this pathogenic infection. Despite C. 
albicans is still the focus of a wide range of studies, some researches have been 
demonstrated a significant increasing of infections caused by NCAC species. There are 
some associated factors with the virulence. The presence of hemolytic exoenzymes is 
very important because it allows an acquisition of iron ions from hemoglobin, by yeasts. 
Moreover, there is a positive correlation between this metal and the establishment and 
dissemination of infections. The metabolic activity and the capacity of biofilm 
formation also appear like important correlating factors of pathogenicity, once they 
interfere in the level of virulence expression and in the level of resistance to antifungal 
agents. A high metabolic activity of NCAC species was demonstrated, which could be a 
cause of the increasing frequency of fungal infections related to these yeasts, including 
the possibility of systemic infections. According to these facts, it was possible to 
demonstrate the complexity of the epidemiological chain of colonization – infection 
processes. Like expression of virulence-associated factors are strain dependent, an 
accurate identification of yeasts and their virulence-associated factors is essential to 
detect the emergence of yeasts and to predict the antifungal agents response, 
considering the increasing tolerance and antifungal resistance mechanisms [1,2,20,22–
24].  
Due to the increasing evidence of antimicrobials and antifungals resistance, several 
studies have been developed towards the identification and evaluation of efficient 
alternative therapeutics. Natural products, in particular, those from plants, have been 
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explored with that purpose; the therapeutic potential of phytochemicals, the synergistic 
effects among them and the related mechanisms of action have been extensively studied 
[25–35]. Nevertheless, many extracts/compounds from plant origin remain unknown 
and could constitute an alternative or complementary treatment for candidiasis.  
Considering all the stated, candidiasis is indeed much more than C. albicans overgrowth 
and, therefore, the most relevant topics involved in this fungal infection are presented 
and discussed in the present manuscript, namely: description of candidiasis and their 
main classes, predisposing factors, diagnosis (signals, symptoms and methods), 
prevention and alternative treatment (diet and nutrition, enhancing immunity system, 
detoxification, natural anti-yeast agents and therapeutical approach) (Figure 1).  
 
2. Description of candidiasis and main classes 
Yeasts are part of the commensal fungi flora of the healthy population. However, with 
the significant and rapid increase in the incidence of opportunistic fungal infections, the 
focus of attention has been the treatment and, above all, prevention of those 
complications. Although other fungi species are involved in nosocomial infections, like 
Aspergillus spp., Zygomyces spp., Fusarium spp., Scedosporium spp., Cryptococcus 
spp., Trichosporon spp., Geotrichum spp., and Rhodotorula spp., C. albicans continues 
to be the most prevalent, counting to 50-90% of the isolates from fungal infections 
[1,9,10,22,36,37].  
Candida albicans is a common species in genitourinary and gastrointestinal tracts of 
healthy people, but it is also able to cause problems, mainly vaginal infections in 
woman. This microorganism is responsible for mouth and mucocutaneous infections. 
However, it has been frequently observed an evolution to chronic forms, generating 
complicated infections, such as septicemia, endocarditis, meningitis, and peritonitis, 
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especially in patients with reduced immune function or taking antibiotic therapies. 
Some reports described that oral candidiasis appeared as early as the 2nd century A.D. 
by Galen, who described it as aphthas albus. Other reviews reported that it was not until 
the mid-19th century that clinical nature of oral candidiasis was defined and the etiologic 
agent identified. Notwithstanding, and despite the other types of mucocutaneous 
candidiasis, oral candidiasis is still the most frequent. There has been a wide variety of 
synonyms used for the members of genus Candida, 166 synonyms being recognized for 
C. albicans worldwide. Actually, there are between 150 and 200 species recognized in 
the genus, but only seven Candida species are classified as having major medical 
importance, being C. albicans the most important one. Other Candida species like C. 
tropicalis, C. glabrata, C. parapsilosis, C. stellatoidea, C. krusei and C. kyfer are 
encountered in human infections [2,5,15,38,39]. 
The increase in the number of organ transplantations, the rise of immunocompromised 
individuals and the use of invasive devices (catheters, artificial joints and valves) are a 
major factor that contributes to higher patient’s susceptibility to nosocomial infections. 
Despite being Candida species the fourth leading cause of hematogenous infections, 
these species are not exclusively related to nosocomial infections (candidemia), because 
the same infections can also occur in healthy population. There are several classes of 
candidiasis, which have become more common in recent years [4,6,13,17,40,41]. 
Depending on body location, the mucocutaneous candidiasis can be classified as: 
genital candidiasis, intrauterine candidiasis, anal candidiasis, nails candidiasis and oral 
candidiasis (Figure 1). 
 
2.1. Genital candidiasis 
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Vulvovaginal candidiasis (VVC) is the most frequent type of genital yeast infection. 
Approximately 75% of women experience, at least once in their lifetime, an episode of 
VVC, 40-50% experience at least one additional episode of infection, 20-50% remain 
without any clinical manifestation, and lastly, 5% experience recurrent VVC episodes 
[9,10,42,43]. Although, not being a threat to life, it is unpleasant and problematic, 
causing a variable degree of itching and whitish discharge, abundant and flocculent. 
This infection is very common in pregnant women, especially in the last trimester of 
pregnancy, when a variation of progesterone, estradiol and glycogen, associated with an 
increase in vaginal pH, favors the emergence of these infections. In this case, special 
attention should be given due to the potential occurrence of contamination of the fetus 
in the uterus, or even the child during childbirth. On the other hand, it has been 
observed that, in individuals with diabetes, the incidence of vaginal candidiasis is 
higher. Similarly, patients submitted to broad-spectrum of antibiotic therapy, used to 
treat bacterial infections, and even the use of oral contraceptives, are also important 
factors associated with higher rates of incidence of VVC [42,44–47]. 
In men, balanitis, which usually appear after sexual contact, is characterized by the 
appearance of a rash, more or less prickly, followed by small pustules on rocking 
groove-preputial discharge, more or less abundant. Although this kind of injury is well 
defined, in particular cases it can extend to the groin and perianal region. The major 
factors associated with this type of infections are antibiotic therapies, diabetes and 
vaginal secretions of the sexual partner [1,17,48]. 
 
2.2. Intrauterine candidiasis 
This type of infection is frequent during pregnancy. It is important to avoid the 
occurrence of this type of intense vaginitis in the last few weeks of pregnancy, because 
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it can complicate and extend to the uterus, infecting the child before birth. At childbirth, 
or in the first hours of life, it can be observed a widespread rash, maculopapular or 
pustular-vesicular. During the following weeks after birth, the clinical status may be 
complicated, extending to other body locations, which usually are treated with local 
antibiotics [5,42,43,49]. 
 
2.3. Anal candidiasis 
This type of infection is characterized by intense itching/pruritus, accompanied by 
burning sensation, and localized erythema around the anus. Skin may appear macerated 
with circumscribed lesions, which may eventually invade the intergluteal groove [49–
51]. This type of infection is most common in children; despite the frequency in women 
due to the use of hormonal contraceptives, intimate hygiene products, clothing and their 
practice of oral and anal intercourse, functioning as transient colonization of local 
organisms shed from the intestinal tract. As candidiasis can be sexually acquired, males 
can be affected, because they may acquire infection from the gastrointestinal tract of 
their partners. However, in some cases, the factors causing that condition are still 
unknown, but seems that the main problem of this pathogenesis are secondary infections 
caused by aerobic and facultative anaerobes microorganisms, such as Staphylococcus 
spp., Streptococcus spp. and Escherichia coli [48,50–52]. 
 
2.4. Nails candidiasis 
Candida species are not considered normal yeasts on nails flora. Therefore, this type of 
infection is a sign of colonization (secondary growth) despite primary infections of nail 
fold and nail bed with Candida species may also occur, which are related to a disease of 
the nails. Onyxisdystrophy or periungal tissue is related to nail disease. This type of 
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infection may appear, like paronychia and onychia. The paronychia is characterized by 
an inflammation, more or less painful, in peripheral skin nail, which appears red and 
brilliant. The predisposing factors are essentially, sex, different traumas (e.g., in 
manicure), professional activity and hormonal variations. Although infrequent in males, 
this infection can appear in cooks, confectioners and employees of canning factories 
[1,17,49]. 
Usually, the nail injury itself, or onyxis (ingrown nail), is secondary to paronychia. It is 
characterized by a progressive striation, dyschromias (discoloration) and opacity of the 
nail plate, which ultimately becomes crumbly. This infection appears abruptly and 
painfully, leading to detachment of the nail and can spread to other nails. Still, it can be 
observed fungal colonization in interdigital areas, by Candida species, commonly 
known as digital intertriginous. Preferentially, it is located in the hands and between the 
ring and middle fingers, although it can also appear in the corners of the fingers. It is 
commonly associated with professions or occupations in which there is a frequent 
contact with water. The injury erythema-scaly, itchy and exudative generally is well 
delimited peripherally and the epidermis appears detached. It is less frequent in feet, but 
can reach one or more commissures of fingers [1,17,49,50].  
Intertriginous can still be located at the level of the submammary, mainly in obese 
women, suprapubic fold, groin and intergluteal cleft. It is characterized by the 
appearance of small vesicles and pustules which, by breakage, give rise to exudative red 
spots [1]. 
 
2.5. Oral candidiasis 
Oral and perioral candidiasis is the more common type of acute mucocutaneous 
candidiasis. It is characterized by the appearance of small spots or whitish papules on 
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the tongue, inside the cheeks and in the palate, forming a creamy and very adherent 
layer mucosa. In some cases, it may extend up and cover the tongue, palate and 
pharynx, but also corners of the mouth could be reached. When this happens, it is 
labeled as angular cheilitis, being evidently a mucosal thickening and cracking. This 
type of candidiasis particularly affects people with immune system disorders and people 
with dental prostheses. It can be also found in patients receiving chemotherapy for 
cancer treatment, or taking immunosuppressive drugs to protect transplanted organs or 
in patients infected by HIV. In children and young people, it may be involved with oral 
("thrush") and lingual disease. In addition, and despite being very rare, esophageal 
candidiasis can occur in patients infected by HIV and cancer [2,5,40,53–55]. 
 
3. Predisposing factors 
Although Candida species is commensal to human organism and virtually present in 
healthy people, in the past two decades, an abnormal overgrowth in the gastrointestinal 
(GI), urinary and respiratory tracts has been observed [2,3,6,10,56]. During some days 
after childbirth, that species colonize the mucosa of GI tract (40-50%) and upper 
respiratory passages, as well as the mouth, pharynx and larynx. Normally, C. albicans 
lives smoothly in the inner warm creases and crevices of the GI tract (and vaginal tract 
in women). During pregnancy, Candida species colonization increases 30-40%, 
depending upon altered immune response, bacterial flora, positive variations of 
glycogen and pH levels; however, mostly during the normal life cycle, other factors can 
affect, such as hygiene and oral contraceptive use, which contributes to 5-30% of the 
infections. In men, up to 10% of these species are found on the genitalia, in the 
transitional zone, between the mucous membrane and the skin [1,13,18,40,44,46]. The 
overgrowth of C. albicans is an important cause of a wide variety of symptoms that 
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affect directly the wellbeing of individuals, therefore there is an urgent need to 
recognize candidiasis as a complex medical syndrome and evaluate the magnitude of the 
problem regarding prevention, which passes through the control of risk factors. 
There are several factors that contribute to yeast infection, which means that 
candidiasis, and more especially chronic candidiasis, is a good example of a 
multifactorial syndrome. In the next steps the major and most important factors are 
explained namely, decreased digestive secretions, dietary factors, nutrients deficiency, 
impaired immune system and underlying disease states, impaired liver function, drugs 
and prolonged use of antibiotics, and altered bowel flora (Figure 1). 
 
3.1. Decreased digestive secretions  
In a normal organism the digestive secretions, such as hydrochloric acid, bile and 
pancreatic enzymes have an important role not only for a correct digestion, but also to 
prevent Candida overgrowth and its penetration into absorptive surfaces in the GI tract. 
Therefore, an improvement of digestive secretions is pivotal and, in some cases, is an 
important step to treat chronic candidiasis.  
Pancreatic enzymes perform an important role as therapeutic agents enabling an 
efficient and complete digestion of proteins and other dietary compounds. Any 
dysfunction on this process leads to several problems, such as food allergies and 
formation of toxic substances. Furthermore, those enzymes are responsible for the 
preservation of the integrity of small intestine without parasites and other opportunist 
microorganisms (bacteria, yeasts, worms, protozoa), helping in the degradation of 
immunocomplexes [57,58].  
The intake of antacids and antiulcer drugs has a high risk of GI infections, showing a 
Candida species overgrowth in the stomach. Therefore, to restore the normal digestive 
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secretions to proper levels, through the use of supplementary hydrochloric acid, 
pancreatic enzymes and substances that promote the normal bile flow, is highly 
important in the treatment of chronic candidiasis [57,58]. 
 
3.2. Dietary factors and nutrients deficiency 
A balanced organism needs all the macro and micronutrients in right proportions and, 
therefore, any unbalanced diet affects the wellbeing of the body and potentiates growing 
and colonization of certain invaders. Some foods, like refined sugars, sucrose, fruit 
juice, honey and maple syrup have an important interference, functioning like growth 
enhancers. Moreover, foods with high content of yeast and fungi favor the growth of 
Candida; some examples are cheeses, alcoholic beverages and dried fruits. Another 
food group that stimulates growth is milk and dairy products, not only because of the 
high content of lactose but also, in some cases, due to the presence of antibiotics. 
Another important situation observed in most individuals with chronic candidiasis, is 
the presence of food allergies, therefore all known allergens should be eliminated 
[40,42,55,57,59–61]. Thus, dietary factors should be monitored according to the needs 
of each individual. 
Some essential nutrients usually in deficit on chronic candidiasis are zinc, magnesium, 
selenium, essential fatty acids, folic acid and vitamins B6 and A [57,59,60,62]. 
Furthermore, iron has been considered as an essential micronutrient rather than a 
supplement, and there are several recent studies that indicate its important role in 
fostering and colonization by microorganisms, including Candida and other yeasts 
[9,42,63–66]. 
 
3.3. Impaired immune system and underlying disease states 
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Dysfunctions of the immune system turn the human body more vulnerable to various 
kinds of infections. Thus, it is of extreme importance to maintain the good conditions of 
the immune system in order to prevent overgrowth of certain microorganisms and 
opportunistic infections. By itself, a weak immune system is already sufficient to 
constrain the health and resistance of individuals, although with the current and 
prolonged/frequent consumption of antibiotics, chemotherapy, steroids, radiation, stress, 
as well as some environmental contaminants, the body is still more susceptible. 
Furthermore, any disease that, directly or indirectly, affects the immune system 
increases the body's susceptibility to the growth and development of pathogenic and 
opportunistic microorganisms. This is the case of some increasing prevalence diseases, 
such as cancer, diabetes, and hypothyroidism, that in addition to debilitate immune 
system of individuals, has led to a continuous and exacerbated prescription of 
immunosuppressant drugs [1,11,17,18,24,37,40,41,67–69]. 
In fact, the most common diseases that predispose to an increased sensitivity to C. 
albicans overgrowth are diabetes mellitus, cancer, leukemia, AIDS, thyroid dysfunction 
and other diseases, in which host defense mechanisms are suppressed or adrenal cortex 
steroids/antibiotics/other similar drugs are used (immunosuppressed patients) 
[6,10,12,24,25,37,40,53,56,70–72]. 
 
3.4. Impaired liver function 
The modifications of the liver functions, as a result of injury or chemical causes, can 
change detoxification mechanisms. In this situation, as the liver is not able to perform 
its functions properly, toxins are absorbed by the intestine being accumulated, which 
affects more the liver and other organs function, and increase the body's sensitivity to 
chemicals. The accumulation of toxins in the body, as a result of liver damage, 
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associated with changes in the mechanisms of detoxification, also stimulates C. albicans 
overgrowth. One way to diagnose if liver function is affected or if the mechanism of 
filtration of the blood is not properly being done, is through the manifestation of 
symptoms (e.g., psoriasis, premenstrual syndrome, among others) of chronic candidiasis 
outside of digestive tract [57,60,73,74]. 
 
3.5. Drugs and prolonged use of antibiotics  
Antibiotics have been identified as a major responsible factor for the development of 
chronic candidiasis. Since its mode of action is based on the elimination of intestinal 
bacteria, responsible for preventing the growth of yeasts and other pathogenic 
organisms, as well as suppressing the immune system, antibiotics action result in a C. 
albicans overgrowth. This situation becomes shortly a vicious cycle: a person with an 
alteration of the immune system is more susceptible to infections and, consequently, 
more infections will appear – increasing the doses and frequency in the consumption of 
antibiotics. This fact not only favors the overgrowth of C. albicans and other yeasts, but 
particularly bacteria, which increasingly develop mechanisms of resistance against 
antibiotics [6,17,42,57,69]. 
An established fact is that, the indiscriminate use of antibiotics substantially increases 
the risk of developing complications caused by C. albicans and other resistant 
pathogens. This is particularly important in hospitals because nosocomial infections by 
resistant microorganisms often lead to lethal complications. Therefore, the reduction of 
the prescription and use of antibiotics can be considered an effective alternative to 
control and/or minimize the resistance problem. Another alarming factor is the 
widespread use of antibiotics in animals, which not only contribute to microbial 
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resistance in animals themselves, but also indirectly affect humans: antibiotic resistance 
and consumption of food contaminated by antibiotics [1,6,17,23,40,42,43,46,70,75,76].  
The increasing incidence of Crohn’s disease and other inflammatory bowel diseases, 
which previously were only prevalent in populations with a strong genetic component, 
is also an important factor [77–86]. 
Other drugs that could favor C. albicans overgrowth are corticosteroids, oral 
contraceptives and anti-ulcer drugs. It should be emphasized that individuals who take 
anti-ulcer drugs, like ranitidine and cimetidine, may develop C. albicans in the stomach 
[6,7,40,42,43,46]. 
 
3.6. Altered bowel flora 
As described, drugs and other chemical compounds greatly affect the wellbeing of the 
body. If the liver does not work properly, products and metabolites resulting from poor 
digestion are accumulated in the body causing toxicity and, at the same time, favoring 
pathogenic strains, and also C. albicans overgrowth. Therefore, intestinal flora is of 
utmost importance in maintaining proper intestinal health and balance, being involved 
in the maintenance of nutritional status, immune system function, cholesterol 
metabolism, carcinogenic agents and aging. It is imperative to promote healthy and 
growth of beneficial intestinal flora, not only after taking antibiotics, but also in other 
situations. It should also be noted that chronic stress greatly affects the balance of 
intestinal flora and suppresses the immune system function. In other hand, especially in 
women, the hormonal balance is very important and the oral routine of contraceptive 
use is itself a predisposing factor to C. albicans overgrowth once it is a causative agent 
of variation in the balance of the intestinal microflora [1,6,9,23,40,42,46,87,88]. 
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4. Diagnosis 
In some cases, the diagnosis of candidiasis becomes quite complicated and difficult to 
establish, since the patients present different signals and symptoms according to age, 
gender, host resistance and exposure to environmental factors. Nevertheless, some tools 
could be used to screen and determine the presence of yeast infections (diagnosis) 
namely, questionnaire, comprehensive digestive stool analysis (CDSA) and laboratorial 
techniques (Figure 1). 
 
4.1. Signals and symptoms 
Despite fungi and other microbials being widespread in the environment, the systemic 
infections thrive very slowly. Most of the times, the individual infected does not have 
symptoms or visible signals. According to some authors, namely, oral candidiasis is 
classified considering the following aspects: duration (acute or chronic), clinical 
features, like color (erythematous/atrophic), location (median rhomboid glossitis, 
denture stomatitis, multifocal candidiasis, angular cheilitis), presence of skin lesions, as 
well as oral lesions (mucocutaneous), and association with an immunocompromised 
host (HIV associated). Other clinical aspects included hyperplastic or hypertrophic 
appearance, characterized by papillary hyperplasia of the palate, candida leukoplakia 
and hyperplastic median rhomboid glossitis [1,5,17,48,49,57,59,60]. 
In a more developed stage of infection, a simple sensation of flu or constipation could 
occur, like cough or fever, chest pain, chills, weight loss or breathing difficulties. 
However, the type and the intensity of signals and symptoms depend on the type and 
location of the infection. One of the major explanations for yeasts overgrowth is that the 
immune system mechanisms are depleted, or the normal lining of the intestinal tract is 
damaged. When this happens, the body can absorb yeast cells, particles of yeast cells, a 
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wide of toxins and other substances, resulting in the development of yeast syndrome 
[5,49,62]. 
The major symptoms of patients with yeast infection are divided in different categories, 
which are described below. General symptoms include chronic fatigue, loss of energy, 
general malaise, and decreased libido. Other category includes gastrointestinal 
symptoms, like thrush, bloating, gas, intestinal cramps, rectal itching, and altered bowel 
function. In genitourinary system, the major complaints are vaginal yeast infection and 
frequent bladder infections. Depression, irritability and inability to concentrate are the 
general complaints of nervous system. The occurrence of allergies, chemical 
sensitivities and low immune function are also very frequent. A great majority of 
patients has shown, in the past history, one or more of these conditions: chronic vaginal 
yeast infections; chronic antibiotic use for infections or acne; oral birth control and oral 
steroid hormone usage, as well as premenstrual syndrome; sensibility to foods, 
chemicals and other allergens; endocrine disturbances; eczema; psoriasis; irritable 
bowel syndrome. One of the most important aspects is that most patients have craving 
for foods rich in carbohydrates or yeast [1,5,49,62]. 
Occasionally, patients saying that “feel sick all over” characterize the syndrome. It is 
important to consider that women patients have eight times more yeast infections 
compared to men, due to the effects of estrogen, birth control pills and the large number 
of antibiotics prescriptions [1,5,49,62]. 
 
4.2. Diagnosis methods 
4.2.1. Questionnaire 
C. albicans questionnaire is one of the most useful screening methods to determine and 
understand the likelihood of yeast-related illness. It is composed by three sections: 
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anamnesis, main symptoms and other symptoms. The complete evaluation is made by 
the sum of those sections, directing the treatment and establishing hierarchy of 
intervention. Although Candida questionnaire can be profitable, clinical evaluation is 
one of the most important and credible methods of diagnosis, including patient’s history 
and clinical picture. Promptly, and according to the necessity, laboratory examinations, 
like stool cultures for C. albicans and measurement of antibody levels or antigens in the 
body, are very useful and accurate [5,43,57]. 
 
4.2.2. Comprehensive digestive stool analysis (CDSA) 
The stool sample culture exam is very common, but it is inconclusive and provides little 
information in the case of active infection. CDSA is an extremely useful and effective 
method to determine the existence of some digestive disturbances, functional and 
clinical status of the GI tract, which can be one of the major responsible factors of 
Candida overgrowth. It also allows determination of the symptoms that are not related 
with Candida overgrowth, but associated with the intestinal bacteria overgrowth or 
presence of inflammatory bowel disease [57,59,60,62,89]. 
CDSA is also considered very important to maintain the optimal functioning and 
ecology of the GI tract to improve human health and wellness. This noninvasive method 
of diagnosis can be considered as an integrated tool. It provides advanced clinical 
insight and allows, carefully, an evaluation and examination not only of digestion, 
absorption and intestinal capacity or function, but also of intestinal environment, gut 
immunology and metabolism, microflora balance and colon risk cancer. Therefore, in 
the last instance, it is helpful in the diagnosis and monitorization of disease-specific 
infections or conditions, but also determines the etiology of diseases [57,59,60,62,89]. 
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4.2.3. Laboratorial techniques of diagnostic 
Laboratory techniques only confirm the patient's history, physical examination and 
CDSA, only few additional data is provided and it is rarely used. However, there are 
situations in which the physician or the patients intend to objectify which Candida 
species is the main ethiogenic agent. In this case, microbiologic, molecular and 
biochemical assays could be used. For example, the blood analysis can be useful, not 
only as a method of determination/confirmation, as well as to monitoring therapy. This 
test is based on measuring the level of antibodies to Candida antigens. Other 
techniques, like urine test, used to measure yeast metabolites and intestinal 
permeability, help to assess metabolic reasons for candidiasis [57,59,60,62]. 
 
5. Prevention 
Considering the facts described above, and being C. albicans a commensal 
microorganism and that is present in all people, it is important to control the number 
and magnitude of its population. As prevention is the most effective treatment, much 
more than the eradication of the yeast with antifungal agents – synthetic or naturals, it is 
fundamental to address and amend the predisposing factors. Therefore, maintaining a 
good personal hygiene is essential. Moreover, being woman more prone to this kind of 
infection, a good vaginal and oral hygiene is essential, in order to reduce the probability 
of candidiasis occurrence [5,17,42,46,49,59,60]. Some general guidelines for personal 
hygiene are listed in Table 1. 
 
Since deep infections have been increasing, mainly in hospitals, the following aspects 
should be considered: probes and catheters should be regularly monitored and removed, 
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as soon as possible; and the frequency, duration and amplitude of the quantities of 
antibiotics should be kept to a minimum [3,6,9,14,49,72,90]. 
Not less important, is to avoid certain risk factors, such as diets rich in sugar and poor in 
vitamins and minerals, or the use of antibiotics. 
 
6. Alternative treatment 
C. albicans is an opportunistic yeast that cause infectious but, in some levels, lives and 
grows inside most human bodies. In normal situations, Candida is not harmful because 
our bodies are able to keep it under control, mainly by immune cells and probiotic 
bacteria. However, some factors previously discussed, like allergies, high-sugar diets, 
medications/drugs, and other factors that directly affect the normal balance of intestinal 
environment, can kill the friendly bacteria and stimulate the overgrowth of pathogenic 
microorganisms [1,68,69,84,87,88]. Therefore, the best complementary treatment is to 
reduce and control Candida levels. Several recommendations/interventions are 
necessary according to each person. In most of the cases, direct therapy for Candida 
species destruction is advantageous, because it assists the body on lowering Candida 
species to controllable levels [49,57,59,60]. However, depending on the profile of the 
patient, other procedures (diet and nutrition, enhancing immunity system, detoxification 
and natural anti-yeast agents; Figure 1) are required and will be discussed.  
 
6.1. Therapeutic considerations 
6.1.1. Diet and nutrition 
As previously discussed, some dietary factors affect and promote the overgrowth of C. 
albicans; therefore, following a special diet for the treatment of candidiasis is crucial. 
The most important elements are refined sugars, such as sucrose, fruit juice, honey and 
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other sweet foods, because C. albicans grows in sugar environments. Foods with high 
content of fungi or yeasts, like alcoholic beverages, cheeses, dried fruits, bread and 
fermented products should be avoided, as also milk and dairy products due to the high 
content of lactose and, in some cases, trace levels of antibiotics. Likewise, all the 
allergens present in food should be eliminated, since allergies weaken the immune 
system, promoting the growth of pathogens. There are several reasons to restrict or 
eliminate milk and other dairy products, not only for the high levels of lactose, that 
promote Candida overgrowth, but also because it is one of the most frequent food 
allergens, and the presence of trace levels of antibiotics disrupt the GI bacterial flora 
[42,55,57,59,60,70,87]. 
Food allergies could be assessed by some immunoanalytical methods, such as ELISA 
tests, which determine both IgE- and IgG-mediated food allergies and often help in the 
identification of allergies [91–95]. 
Foods that can be eaten without problems and/or constraints are vegetables, sources of 
proteins, such as fish, meat and organic poultry, legumes and whole grains. The latter 
consumption is dependent of each individual tolerance. For fruits, although being the 
majority alkaline, the recommendation is to eliminate the consumption for a month of 
citrus and acidic fruits (e.g., oranges, grapefruit, lemons, tomatoes, pineapple, and 
limes); afterwards the consumption can be made twice a week. Apples, cranberries, 
cherries, pears and other soft fruits can be daily consumed. Although the existence of 
conflicting opinions, the consumption of yogurt containing live probiotic cultures is 
recommended in order to replace friendly bacteria. In some cases, for vaginal 
candidiasis, a natural unprocessed and unsweetened yogurt can be applied directly into 
the vagina or a mixture of one small container of plain yogurt with an equal amount of 
water can be used as a douche, once or twice a day, until improvement is observed. 
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Alternatively, or complementary, it is also possible to take supplemental acidophilus or 
bifidus, or to open two capsules of acidophilus and add the contents to a douche. It is 
also recommended to consume daily oat bran and/or flaxseed, not only as a source of 
fiber, being the latter also very effective due to antifungal properties [49,57,59,60].  
Table 2 summarizes the most important dietary aspects in fungal infections.  
 
6.1.2. Enhancing immune system 
In most cases of chronic candidiasis, the immune system is altered (mostly depressed) 
allowing a quick growth of C. albicans. This explains why the patients have repetitive 
cycles of infection that lead to increase damages, and further resistance weakening. 
Thereby, it is very important to potentiate the immune function, in order to protect the 
organism against foreign/opportunist agents. Additionally, in patients suffering from 
AIDS or taking immunosuppressive drugs, the immune system is affected, which favors 
the C. albicans overgrowth. In both cases, the prevalence of candidiasis is considerable, 
being the strength of the immune function very important. In some cases, the debility of 
the immune system is related to a decrease in thymus function, represented by an 
impairment of cell-mediated immunity [57,59]. There are some points that help to 
strength the immune function and that eliminate, suppress or amend the causes of 
depressed immune function. The major triggers of impaired immunity and that lead to 
C. albicans overgrowth are antibiotics, corticosteroids and other drugs that suppress 
immune system, as also nutrients deficiency, food allergies and stress 
[1,37,40,53,69,75,80,84]. 
Accordingly, restoring proper immune function is one of the major objectives in the 
treatment of chronic candidiasis; to reach this goal, some strategies could be followed: 
stress management, diet restriction, nutritional supplementation, glandular therapy, 
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exercise and the use of plant-based medicines. However, as the clinical remission of 
candidiasis is directly dependent on T-cells function, it is also crucial to improve 
thymus gland function. To achieve this, it is necessary to guarantee an adequate intake 
of antioxidants, through nutritional supplementation, such as carotenes, vitamins A, C 
and E, zinc and selenium. Some plants could be used to complement this intervention 
namely, Echinacea angustifolia, Hydrastis canadensis and Glycyrrhiza glabra 
[49,57,59,62,96]. 
 
6.1.3. Detoxification 
The human body is continuously exposed to substances and toxic agents, which 
accumulates in the body. Therefore, the body detoxification process is continuous, 
being widely recognized that different substances (e.g., heavy metals, pesticides, 
microbial toxins, solvents) have considerable interferences in the health and well-being 
of individuals. The liver is an extremely important organ in the body, responsible for 
vascular, metabolic and secretory functions. In addition, it is also responsible for the 
detoxification of all the chemical substances at which we are constantly exposed (not 
only those ingested through diet and as a result of the environment interaction, but also 
those resulting from endogenous metabolic processes, such as drugs and other cellular 
metabolisms). It has been observed that the majority of subjects with C. albicans 
overgrowth, present some problems in liver detoxification mechanisms. Moreover, the 
presence of multiple chemical sensibilities and allergies is frequent in patients with 
chronic candidiasis, which is a direct indicator of problems in detoxification reactions. 
The damage of liver is an underlying factor in chronic candidiasis, as well as in chronic 
fatigue, because when the liver is damaged by chemical toxins and others, the immune 
function is severely compromised. Thus, enhanced liver function is vital, not only 
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before, but also during and even after procedures that destroy yeasts, in order to increase 
the likelihood of success in candidiasis treatment [49,57,59,60,62]. 
Some procedures could help in the improvement of detoxification process by liver 
(Table 3). 
 
6.1.4. Natural anti-yeast agents 
Natural anti-yeast agents with proven activity against C. albicans can be used to treat 
the infection concomitantly to other procedures. Nevertheless, to be effective as primary 
therapy, predisposing factors to chronic candidiasis, diet and lifestyle should also be 
taken into account. The most studied compounds that act as natural agents against C. 
albicans are caprylic acid; berberine-containing plants; probiotics; grapefruit seed 
extract; garlic; tea tree oil; and enteric-coated volatile oil preparations containing 
oregano, thyme, peppermint, and rosemary; propolis; ginger and cinnamon. However, 
the occurrence of Herxheimer reaction is very frequent when an effective anti-yeast 
therapy is used, due to the rapid elimination of the microorganisms, and subsequent 
absorption of large amounts of yeast toxins, cell particles and antigens. The mentioned 
reaction can be eliminated through supporting liver function, following dietary 
recommendations and starting anti-yeast medications in low and gradually increasing 
doses [49,57,59,60,97]. 
 
6.2. Therapeutic approach 
In order to successively control the growth of C. albicans and related infections 
(candidiasis), a therapeutic intervention is required.  
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After identification of the predisposing factors, it is essential to develop a diet to control 
C. albicans growing. The most commonly used substances and phytotherapics in the 
complementary treatment of candidiasis are presented in Table 4. 
 
Besides the mentioned phytotherapics there are other plants with documented antifungal 
activity, particularly against C. albicans, such as essential oils from ginger (Zingiber 
officinale) [98–100], cassia (Cinnamomum cassia) [98,101] and others Cinnamomum 
species [32,102], chamomile (Matricaria chamomilla) [57,103,104], lemon balm 
(Melissa officinalis) [32,101,105], thymus (Thymus vulgaris) and rosemary 
(Rosmarinus officinalis) [101,106–109].  
Nevertheless, there are still several unknown compounds from plants, that could act 
synergistically, among themselves and with other natural compounds, against yeast 
infections [57,59,60,97,110]. 
Other aspects should also be considered namely, rest and liquids intake mainly 
vegetable diluted juices, soups and plant infusions. Moreover, it is necessary to promote 
a positive mind and help patients to cope stress. Alcohol, simple sugars, tobacco and 
cholesterol should be avoided due to their capacity of stimulating C. albicans 
overgrowth, and impair the immune function. The support to thymus gland function is 
also provided by 500 mg of crude polypeptide fractions, twice daily 
[57,59,60,62,96,111]. 
The body ability to detoxify and eliminate some substances is mostly dependent of 
healthy diet and lifestyle. As previously mentioned, liver is the responsible for the 
detoxification of all chemical substances. Therefore, the optimization of liver function, 
promoting their protection and using lipotropics factors, accelerates the elimination and 
fat deposition in liver, and could offer significant benefits [57,59,60,97]. In some cases, 
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the use of formulas containing natural plant fibers derived from psyllium seed, kelp, 
agar, pectin and plant gums, is necessary to help elimination of toxic substances and 
protect the bowel wall from irritation. Moreover, these fiber formulas promote natural 
bowel movements and, if anti-yeast therapies are employed, they guarantee that dead 
yeast cells are excreted and not absorbed; 3-5 g of soluble fiber at bedtime are required 
for the treatment of candidiasis [57,59,60,87,88,112,113]. 
The repair of intestinal flora is another crucial factor. Particularly, Lactobacilus 
acidophilus, Bifidobacterium bifidum, Lactobacillus bulgaricus and Streptococcus 
thermophilus are very important, not only as antifungals, antibacterials and antivirals, 
but also in digestion and in production of vitamins and other substances important to 
maintain gut and the all body healthy. The recommendation is a product containing 4-10 
billion viable active organisms, 30 minutes after a meal. However, some foods, like 
yogurt and kefir, could also be a good source of probiotics, but is necessary to take care, 
mainly due to fact that the yogurt itself does not have the necessary amount of bacteria 
and, in other hand, the presence of sugar promotes the overgrowth of C. albicans and 
other microorganisms. Therefore, the yogurt should have the proper bacteria and should 
not be sweetened [57,59,60,87,88,112,113]. 
Lastly, the use of nutritional supplements or herbs seems to be the best option to help 
and control C. albicans overgrowth, and to promote a healthy bacterial flora. Antifungal 
drugs should be prescribed only if necessary. In most cases, these therapeutic 
interventions are effective to threat candidiasis, including chronic candidiasis. However, 
if the patient cannot achieve a significant improvement and/or eradicate the infection, it 
is necessary to perform a deeper evaluation [57,59,60,62]. If the organism is still 
present, after repeat stool cultures and measure antigen levels, antibiotics could be 
prescribed, combined with other recommendations [57,59,60]. Despite until now the 
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majority of studies focused essentially in the role of oils of plants, currently other 
natural matrices preparations have been studied, namely, aqueous and alcoholic 
extracts. It is very important to underline that the use of plants and other botanical 
preparations are used, since ancient times, by primitive societies, due to healing 
properties and therapeutic and psychotherapeutic benefits. It is important to address the 
fact that plants are widely used to obtain a large variety of drugs, being used in folk 
medicine for a long time [26–29,32–35]. Concerning that plants represent an economic, 
easily and which are accessible for all of people, they can be used into a variety of 
diseases, constituting an excellent source of biomolecules able to act like natural 
antifungal agents and, at the same time, to encourage the search for other alternative 
treatments. They can be used, both to complement a conventional treatment with 
antifungal agents, and singly like a natural alternative treatment. In both situations, the 
counseling and following of a growing control diet are crucial to ensure successful of 
therapy. 
Moreover, despite the increasing interest of several studies towards the identification of 
several compounds with therapeutic potential and their synergistic effect, in 
combination with other compounds, many properties of plants remain unknown, as well 
as their main compounds. Thus, not only it is necessary to deepen the study of other 
preparations of known plants but also investigate other therapeutic effects provided by 
plants and the major responsible compounds. 
 
7. Concluding remarks 
All people are exposed to a variety of candidiasis predisposing factors, and some of 
them are impossible to avoid. Candidiasis can affect different parts of the body (nails, 
GI tract, and vagina, among others) being characterized by several symptoms, which 
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often-difficult diagnosis; additionally, the individual characteristics alter the 
manifestation of signals and symptoms. As this infection is very uncomfortable and, in 
some cases, offers a considerable health risk, the major and most important aspect is 
prevention. Therefore, there are several aspects to consider and include in the daily 
routine, which at first might seem insignificant, but that could provide a strength 
protection. 
To combat the infection different procedures are necessary according to the pathologic 
conditions of the patient; if all daily care is considered, the probability of the infection 
occurrence will be considerably reduced. However, in face of an infection, a rapid 
intervention is necessary and, for this, other alternatives to antifungals and 
antimicrobials are necessary. 
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Figure 1. Representative scheme of interactions between the main variables related to 
candidiasis. 
  
Prevention 
Personal hygiene 
Dietary factors 
Immune system 
Alternative treatment 
Diet and nutrition 
Enhancing immune system 
Detoxification 
Natural anti-yeast agents 
Therapeutical approach 
Diagnosis 
Signals 
Symptoms 
Diagnosis methods 
Predisposing factors 
Decreased digestive secretions 
Dietary factors and nutrients deficiency 
Impaired immune system and 
underlying disease states 
Impaired liver function 
Drugs and prolonged use of antibiotics 
Altered bowel flora 
Prolonged antibiotic use 
Candidiasis classes 
Genital candidiasis 
Intrauterine candidiasis 
Anal candidiasis 
Nails candidiasis 
Oral candidiasis 
40 
Table 1. Main general guidelines for personal hygiene [49,59,60,62] 
 
 Procedures 
Superficial infections 
Avoid contact with other body parts, as well as with other 
persons 
Maintain the skin clean and dry 
During menstruation, compresses without cosmetic 
products should be used 
Vaginal candidiasis 
Avoid frequent use of vaginal douches and intimate 
hygiene products (they alter the normal vaginal pH, 
causing unbalance and favoring the onset of infection) 
Maintain external vaginal area completely dry 
Avoid prolonged use of bathing suit or damp or wet 
underwear 
The act of cleaning up should always be done backward 
Avoid sexual relations during antifungal therapy 
Personal belongings 
Bed linen, bathroom and personal clothing should be 
washed with very hot water, separated from the others at 
home and disinfected after use 
Avoid tight clothing and use cotton underwear 
 
  
41 
Table 2. Dietary considerations in the treatment of candidiasis [57,59,60,62,97] 
 Food characteristics Food products 
To avoid 
Refined carbohydrate sources Refined sugars (sucrose, fructose, corn 
syrup), fruit juice, honey, maple syrup 
Fungi and/or yeast sources Alcoholic beverages, dried fruits, 
cheeses, peanut 
Lactose and antibiotic sources Dairy products 
Allergenic foods Dairy products, eggs, chocolate, fried 
and processed foods, wheat, peanuts 
To limit Carbohydrate sources Corn and potatoes 
To consume 
Vitamin sources Vegetables, fruits (apples, pears, 
cranberries, cherries, blueberries and 
other soft fruit) 
Protein sources Fish, meat and biological poultry 
Fiber sources Whole grains, ground flaxseeds 
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Table 3. Procedures to improve liver function and detoxification [49,57,59,60,97] 
 
 Procedures 
Improve liver function 
Consuming garlic, onions, chlorella, spirulina, wheatgrass;  
Diet based on fresh fruits and vegetables, whole grains, 
legumes, nuts and seeds; 
Avoiding alcohol and adopt others healthy lifestyles; 
Supplementation with a high-potency multiple vitamin and 
minerals; 
Regular exercise 
Improve detoxification 
Diet based on high-fiber plant foods to supplying a high 
amount of dietary fiber; 
If necessary, prescribed additional fiber formulas- 3 to 5 g of 
soluble fiber at the bedtime- composed by natural plant fibers, 
derived from psyllium seed, kelp, agar, pectin, guar, and 
others that promote a natural mechanism of bowel movement; 
Using lipotropic formulas* such as choline, betaine and 
methionine or cysteine, silimarin to protect the liver  
*The importance of lipotropic factors is related to increased levels of two important liver 
substances: SAMs (S-adenosylmethionine) and glutathione, that are the major lipotropic 
and detoxifying compounds in the liver, respectively. 
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Table 4. Substances and phytochemicals commonly used in alternative treatment of 
candidiasis 
 
Substance Dosage/Description 
High-potency complex of multivitamins 
and minerals formula 
Hypoallergenic formulas, free of yeasts 
Zinc picolinate 45 mg/day 
Selenium 200 µg/day 
Caprylic acid Formula of slow liberation (1 g with meals) 
Probiotics (intestinal flora) Products containing Lactobacillus 
Fiber supplement Guar gum, pectin or psyllium seeds (1 
teaspoon before bedtime) 
Phytotherapics Dosage/Description 
Tabebuia impetiginosa (lapacho) 15-20 g of bark in 0.5 L boiling water for 5-
15 minutes, 3-4 times/day; 
Berberis vulgaris (barberry) The following doses, 3 times/day: 
Dried bark of the root (as tea): 1-2 g 
Tincture (1:5): 4-6 mL (1-1 and ½ teaspoon) 
Liquid extract (1:1): 0.5-2 mL (¼-½ 
teaspoon) 
Powdered solid extract (4:1): 250-500 mg 
Hydrastis Canadensis (goldenseal) The following doses, 3 times/day: 
Dried root (as tea): 1-2 g 
Tincture (1:5): 4-6 mL (1-1 and ½ teaspoon) 
Liquid extract (1:1): 0.5-2 mL (¼-½ 
teaspoon) 
Powdered solid extract (4:1): 250-500 mg 
Origanum vulgare (oregano) oil 300-500 mg by capsule or liquid form, 3 
times/day, with meals to avoid digestive 
unease 
Allium sativum (garlic) Actual guidelines based on allin (10 mg) and 
allicin (4000 µg), which is equivalent to 4000 
mg of fresh garlic or 500-1000 mg of aged 
garlic 
Citrus paradise (grapefruit) seed extract 200 mg, 2-3 times/day 
 
